$511.16 Million in Sales Expected for LHC Group, Inc. (LHCG) This Quarter
Brokerages expect LHC Group, Inc. (NASDAQ:LHCG) to announce sales of $511.16 million for the current quarter, according to Zacks Investment Research. Five analysts have provided estimates for LHC Group’s earnings, with the highest sales estimate coming in at $516.50 million and the lowest estimate coming in at $494.38 million. LHC Group posted sales of $295.98 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 72.7%. The company is scheduled to report its next earnings results after the market closes on Wednesday, May 8th.
According to Zacks, analysts expect that LHC Group will report full year sales of $2.11 billion for the current fiscal year, with estimates ranging from $2.11 billion to $2.13 billion. For the next financial year, analysts forecast that the business will post sales of $2.22 billion, with estimates ranging from $2.19 billion to $2.27 billion. Zacks’ sales averages are an average based on a survey of research analysts that that provide coverage for LHC Group.
LHC Group (NASDAQ:LHCG) last posted its earnings results on Wednesday, February 27th. The health services provider reported $1.03 EPS for the quarter, meeting the Zacks’ consensus estimate of $1.03. LHC Group had a net margin of 3.50% and a return on equity of 8.40%. The company had revenue of $509.80 million for the quarter, compared to analysts’ expectations of $522.21 million. During the same quarter in the prior year, the company posted $0.62 earnings per share. LHC Group’s revenue for the quarter was up 75.1% compared to the same quarter last year.
In other LHC Group news, COO Donald Dwayne Stelly sold 15,151 shares of the business’s stock in a transaction dated Monday, March 11th. The shares were sold at an average price of $107.06, for a total transaction of $1,622,066.06. Following the sale, the chief operating officer now directly owns 92,065 shares in the company, valued at $9,856,478.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Keith G. Myers sold 5,164 shares of the business’s stock in a transaction dated Wednesday, April 3rd. The stock was sold at an average price of $108.75, for a total transaction of $561,585.00. Following the sale, the chief executive officer now owns 96,315 shares in the company, valued at $10,474,256.25. The disclosure for this sale can be found here. Insiders have sold 192,876 shares of company stock worth $20,614,290 over the last quarter. Insiders own 6.80% of the company’s stock.
A number of large investors have recently modified their holdings of LHCG. Bank of New York Mellon Corp increased its stake in shares of LHC Group by 2.9% during the third quarter. Bank of New York Mellon Corp now owns 732,075 shares of the health services provider’s stock worth $75,394,000 after buying an additional 20,567 shares during the period. PNC Financial Services Group Inc. increased its stake in shares of LHC Group by 6.7% during the third quarter. PNC Financial Services Group Inc. now owns 13,223 shares of the health services provider’s stock worth $1,362,000 after buying an additional 826 shares during the period. Riverhead Capital Management LLC increased its stake in shares of LHC Group by 41.5% during the third quarter. Riverhead Capital Management LLC now owns 3,069 shares of the health services provider’s stock worth $316,000 after buying an additional 900 shares during the period. LPL Financial LLC increased its stake in shares of LHC Group by 39.7% during the third quarter. LPL Financial LLC now owns 4,043 shares of the health services provider’s stock worth $416,000 after buying an additional 1,149 shares during the period. Finally, Paloma Partners Management Co purchased a new stake in shares of LHC Group during the third quarter worth approximately $1,784,000. Institutional investors own 93.46% of the company’s stock.
NASDAQ LHCG traded down $0.12 during trading hours on Friday, reaching $99.63. The company had a trading volume of 727,519 shares, compared to its average volume of 258,876. LHC Group has a 1-year low of $67.72 and a 1-year high of $115.54. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.78 and a quick ratio of 1.78. The stock has a market capitalization of $3.12 billion, a P/E ratio of 28.06, a PEG ratio of 1.89 and a beta of 0.91.
LHC Group Company Profile
LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Community-Based Services and Facility-Based Services.
Featured Story: Trading Ex-Dividend Strategy
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.